199 related articles for article (PubMed ID: 26348463)
1. Advances in Molecular Pathology and Treatment of Periampullary Cancers.
Chandrasegaram MD; Chen JW; Price TJ; Zalcberg J; Sjoquist K; Merrett ND
Pancreas; 2016 Jan; 45(1):32-9. PubMed ID: 26348463
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and spectrum of pathogenic germline variants in intestinal and pancreatobiliary type of ampullary cancer.
Kumari N; Singh RK; Mishra SK; L R; Mohindra S; Krishnani N
Pathol Res Pract; 2021 Jan; 217():153309. PubMed ID: 33341547
[TBL] [Abstract][Full Text] [Related]
3. Distribution and pathological features of pancreatic, ampullary, biliary and duodenal cancers resected with pancreaticoduodenectomy.
Chandrasegaram MD; Chiam SC; Chen JW; Khalid A; Mittinty ML; Neo EL; Tan CP; Dolan PM; Brooke-Smith ME; Kanhere H; Worthley CS
World J Surg Oncol; 2015 Feb; 13():85. PubMed ID: 25890023
[TBL] [Abstract][Full Text] [Related]
4. Low incidence of KRAS, BRAF, and PIK3CA mutations in adenocarcinomas of the ampulla of Vater and their prognostic value.
Kwon MJ; Kim JW; Jung JP; Cho JW; Nam ES; Cho SJ; Kim JS; Park HR; Min SK; Seo J; Min KW; Kim DH; Jeon JY
Hum Pathol; 2016 Apr; 50():90-100. PubMed ID: 26997442
[TBL] [Abstract][Full Text] [Related]
5. Intestinal-type and pancreatobiliary-type adenocarcinomas: how does ampullary carcinoma differ from other periampullary malignancies?
Westgaard A; Pomianowska E; Clausen OP; Gladhaug IP
Ann Surg Oncol; 2013 Feb; 20(2):430-9. PubMed ID: 22956064
[TBL] [Abstract][Full Text] [Related]
6. Non-ampullary-duodenal carcinomas: clinicopathologic analysis of 47 cases and comparison with ampullary and pancreatic adenocarcinomas.
Xue Y; Vanoli A; Balci S; Reid MM; Saka B; Bagci P; Memis B; Choi H; Ohike N; Tajiri T; Muraki T; Quigley B; El-Rayes BF; Shaib W; Kooby D; Sarmiento J; Maithel SK; Knight JH; Goodman M; Krasinskas AM; Adsay V
Mod Pathol; 2017 Feb; 30(2):255-266. PubMed ID: 27739441
[TBL] [Abstract][Full Text] [Related]
7. Histological and Molecular Subclassification of Pancreatic and Nonpancreatic Periampullary Cancers: Implications for (Neo) Adjuvant Systemic Treatment.
Erdmann JI; Eskens FA; Vollmer CM; Kok NF; Groot Koerkamp B; Biermann K; van Eijck CH
Ann Surg Oncol; 2015 Jul; 22(7):2401-7. PubMed ID: 25503345
[TBL] [Abstract][Full Text] [Related]
8. Epidermal growth factor receptor signaling pathway is frequently altered in ampullary carcinoma at protein and genetic levels.
Mikhitarian K; Pollen M; Zhao Z; Shyr Y; Merchant NB; Parikh A; Revetta F; Washington MK; Vnencak-Jones C; Shi C
Mod Pathol; 2014 May; 27(5):665-74. PubMed ID: 24186143
[TBL] [Abstract][Full Text] [Related]
9. Ampullary and periampullary tumors: translational efforts to meet a challenge in diagnosis and treatment. Highlights from the "2011 ASCO Gastrointestinal Cancers Symposium". San Francisco, CA, USA. January 20-22, 2011.
Kang SP; Saif MW
JOP; 2011 Mar; 12(2):123-5. PubMed ID: 21386636
[TBL] [Abstract][Full Text] [Related]
10. Pancreatic tumours: molecular pathways implicated in ductal cancer are involved in ampullary but not in exocrine nonductal or endocrine tumorigenesis.
Moore PS; Orlandini S; Zamboni G; Capelli P; Rigaud G; Falconi M; Bassi C; Lemoine NR; Scarpa A
Br J Cancer; 2001 Jan; 84(2):253-62. PubMed ID: 11161385
[TBL] [Abstract][Full Text] [Related]
11. Ampullary cancer of intestinal origin and duodenal cancer - A logical clinical and therapeutic subgroup in periampullary cancer.
Chandrasegaram MD; Gill AJ; Samra J; Price T; Chen J; Fawcett J; Merrett ND
World J Gastrointest Oncol; 2017 Oct; 9(10):407-415. PubMed ID: 29085567
[TBL] [Abstract][Full Text] [Related]
12. Gene expression profiling of ampullary carcinomas classifies ampullary carcinomas into biliary-like and intestinal-like subtypes that are prognostic of outcome.
Overman MJ; Zhang J; Kopetz S; Davies M; Jiang ZQ; Stemke-Hale K; Rümmele P; Pilarsky C; Grützmann R; Hamilton S; Hwang R; Abbruzzese JL; Varadhachary G; Broom B; Wang H
PLoS One; 2013; 8(6):e65144. PubMed ID: 23776447
[TBL] [Abstract][Full Text] [Related]
13. Distinguishing pancreatic carcinoma from other periampullary carcinomas by analysis of mutations in the Kirsten-ras oncogene.
Motojima K; Tsunoda T; Kanematsu T; Nagata Y; Urano T; Shiku H
Ann Surg; 1991 Dec; 214(6):657-62. PubMed ID: 1741644
[TBL] [Abstract][Full Text] [Related]
14. Identification and prevalence of potentially therapeutic targetable variants of major cancer driver genes in ampullary cancer patients in India through deep sequencing.
Mishra SK; Kumari N; Krishnani N; Singh RK; Mohindra S
Cancer Genet; 2021 Nov; 258-259():41-48. PubMed ID: 34455261
[TBL] [Abstract][Full Text] [Related]
15. High-grade precursor lesions can be used as surrogate markers to identify the epicenter of periampullary carcinomas.
Jeong BK; Sung YN; Kim SJ; An S; Park H; Hwang HS; Kang HJ; Lee JH; Song KB; Kim KP; Hwang DW; Lee SS; Kim SC; Hong SM
Hum Pathol; 2019 Feb; 84():92-104. PubMed ID: 30261192
[TBL] [Abstract][Full Text] [Related]
16. Updated therapeutic outcome for patients with periampullary and pancreatic cancer related to recent translational research.
Buanes TA
World J Gastroenterol; 2016 Dec; 22(48):10502-10511. PubMed ID: 28082802
[TBL] [Abstract][Full Text] [Related]
17. Predictive value of tumor proliferative indices in periampullary cancers: Ki-67, mitotic activity index (MI) and volume corrected mitotic index (M/V) using tissue microarrays.
Aloysius MM; Hewavisenthi SJ; Bates TE; Rowlands BJ; Lobo DN; Zaitoun AM
World J Surg; 2010 Sep; 34(9):2115-21. PubMed ID: 20556608
[TBL] [Abstract][Full Text] [Related]
18. Differential expressions of cyclin D1 associated with better prognosis of cancers of ampulla of Vater.
Chang MC; Chang YT; Sun CT; Chiu YF; Lin JT; Tien YW
World J Surg; 2007 May; 31(5):1135-41. PubMed ID: 17420962
[TBL] [Abstract][Full Text] [Related]
19. [CT-guided percutaneous fine needle aspiration cytodiagnosis of pancreatic and periampullary tumors].
Jia ZG; Pan RQ; Liu DH
Zhonghua Zhong Liu Za Zhi; 1987 Mar; 9(2):124-6. PubMed ID: 3652914
[TBL] [Abstract][Full Text] [Related]
20. Comparison between the location and the histomorphological/immunohistochemical characteristics of noninvasive neoplasms of the ampulla of Vater.
Yamamoto Y; Nemoto T; Okubo Y; Nihonyanagi Y; Ishiwatari T; Takuma K; Tochigi N; Okano N; Wakayama M; Igarashi Y; Shibuya K
Hum Pathol; 2014 Sep; 45(9):1910-7. PubMed ID: 25081540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]